Arquivamento - Art. 36 §1° da LPI
#11.2
07/09/2024
RPI 2792
Application data
Number
112019005815Type
Filing
Publication
PCT
US2017053954 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 07/09/2024. We update with every new RPI gazette, published weekly.
Applicants
GENENTECH, INC.
US
Inventors
N. C. (pessoa física)
US
V. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/401,638 · 09/29/2016
Abstract
Uma terapia de combinação compreendendo um inibidor de MEK, um inibidor de PD-1 ou PD-L1 e um taxano é fornecida para o tratamento de câncer, tal como câncer de mama triplo negativo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
07/09/2024
RPI 2792
#6.23
03/05/2024
RPI 2774
#15.35
10/05/2021
RPI 2648
#1.3
06/25/2019
RPI 2529
#1.1
04/02/2019
RPI 2517
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.